CellaVision AB (CLVSF) achieved all-time high sales in the APAC region, demonstrating strong regional performance. The company reported a strong gross margin of 69%, attributed to a favorable product ...

CellaVision AB (STO:CEVI) presented its Q1 2025 results on April 29, showcasing strong performance across all regions despite a challenging market environment. The company’s stock has responded ...

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Quarterly Performance Highlights CellaVision reported net sales of SEK 191 million for Q2 2025, representing a modest 1.9% increase from SEK 188 million in the same period last year. While organic ...

CellaVision AB ( (CLVSF)) has released its Q2 earnings. Here is a breakdown of the information CellaVision AB presented to its investors. CellaVision AB is a global medical technology company ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from CellaVision ...

Trading in CellaVision shares will commence today on First North in Sweden. Including CellaVision, First North now comprises 95 companies. CellaVision AB develops and markets products for the health ...

Monica Jönsson has been appointed Interim Chief Financial Officer (CFO) and succeeds Magnus Blixt, who has left the company as previously communicated. Monica has extensive experience from leading ...

CellaVision announces today the appointment of Monica Jönsson as Chief Financial Officer (CFO). Monica is currently Interim CFO at CellaVision. Monica Jönsson brings extensive experience from leading ...